Clinical Trials Logo

Clinical Trial Summary

This phase I trial studies how well indocyanine green lymphangiography works in identifying thoracic duct during neck surgery. Diagnostic procedures, such as near infrared fluorescence imaging with indocyanine green may help recognize and prevent injury to thoracic duct during neck surgery.


Clinical Trial Description

PRIMARY OBJECTIVES: I. Feasibility and optimization of thoracic duct identification using indocyanine green (ICG) lymphangiography. II. To explore specifically how identifying the thoracic duct (TD) will prevent injury intra-operatively. III. To understand if a TD injury can be recognized by leakage of fluorescent chyle into the operating field. OUTLINE: Participants receive indocyanine green solution subcutaneously (SC) and undergo near-infrared imaging over 1-2 minutes during their standard of care neck surgery. After completion of study treatment, participants are followed up for up to 1 year. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03532581
Study type Interventional
Source Ohio State University Comprehensive Cancer Center
Contact
Status Completed
Phase N/A
Start date April 23, 2018
Completion date March 7, 2023

See also
  Status Clinical Trial Phase
Withdrawn NCT03971760 - Ideal Drainage Output of Post-operative Neck Suction Drain N/A
Completed NCT00875953 - Use of the Harmonic Scalpel in Neck Dissection N/A
Not yet recruiting NCT05806073 - Elective vs Therapeutic Neck Dissection in Treatment of Patients With Clinical T1/2N1M0 Oral Squamous Cell Carcinoma N/A